company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,5901000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,2075000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4298000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1091000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1320000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,669000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,15354000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2247000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,119000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,6130000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2323000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,835000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,9407000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,,totalassets,Total Assets,=,debit,usd,27008000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1042000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5734000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6776000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,16869000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,16869000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,23645000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-350000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-350000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-350000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,3713000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3363000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,,2012-12-31,2014-02-21 15:03:44+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,27008000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,9595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,300000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3854000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1150000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1234000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1715000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,17848000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2298000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,6277000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1890000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,767000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,9052000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,,totalassets,Total Assets,=,debit,usd,29198000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,431000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6448000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6879000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,17827000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,17827000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,24706000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,1567000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-320000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-442000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,4492000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,4492000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,4492000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,,2013-12-31,2015-02-20 15:18:31+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,29198000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,8975000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,621000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3798000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1172000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,558000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1419000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,16543000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2244000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,123000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,6199000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1993000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1150000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,9465000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,,totalassets,Total Assets,=,debit,usd,28252000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,434000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6441000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6875000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,17800000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,17800000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,24675000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3596000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,1081000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-119000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-981000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,3577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,3577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,,2013-09-30,2013-11-12 16:57:14+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,28252000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,8743000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,11000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3755000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1085000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,626000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1442000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,15662000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2213000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,121000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,6120000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2101000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1693000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,10035000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,,totalassets,Total Assets,=,debit,usd,27910000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,432000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6373000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6805000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,17547000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,17547000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,24352000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4090000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,758000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-121000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1169000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,3558000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,3558000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3558000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,,2013-06-30,2013-08-09 14:48:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,27910000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,6979000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,500000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4299000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1037000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,711000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1397000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,14923000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2200000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,6060000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2153000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1715000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,10046000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,,totalassets,Total Assets,=,debit,usd,27169000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,436000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6330000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6766000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,17446000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,17446000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,24212000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3961000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,330000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-97000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1237000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2957000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2957000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2957000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,,2013-03-31,2013-05-08 16:53:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,27169000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,8348000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,26000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3735000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1124000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1952000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,896000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,16081000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2485000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,92000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,5862000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1513000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1480000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,8947000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,,totalassets,Total Assets,=,debit,usd,27513000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,4439000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6954000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11393000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,14219000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,159000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,14378000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,25771000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4210000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,535000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-972000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2031000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1742000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1742000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1742000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,,2014-12-31,2016-02-19 12:32:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,27513000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,7719000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,2595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,9000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3592000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1008000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1705000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,927000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,17555000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2432000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,124000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,6002000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1540000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,801000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,8467000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,,totalassets,Total Assets,=,debit,usd,28454000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,323000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6312000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6635000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,17174000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,17174000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,23809000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4099000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,2131000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-672000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-913000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,4645000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,4645000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,4645000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,,2014-09-30,2014-11-07 16:09:36+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,28454000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,9086000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1160000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3684000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1048000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1585000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1231000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,17794000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2387000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,130000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,6244000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1695000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,795000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,8864000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,,totalassets,Total Assets,=,debit,usd,29045000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,271000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6046000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6317000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,17510000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,17510000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,23827000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4012000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,2299000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-673000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-420000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,5218000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,5218000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,5218000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,,2014-06-30,2014-08-07 17:03:44+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,29045000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,8140000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,960000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3650000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1104000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1460000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,2015000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,17329000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2333000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,119000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,6271000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1802000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,803000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,8995000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,,totalassets,Total Assets,=,debit,usd,28657000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,20000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6196000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6216000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,17744000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,17744000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,23960000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3921000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,1874000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-672000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-426000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,4697000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,4697000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,4697000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,,2014-03-31,2014-05-09 14:11:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,28657000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,8399000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,8000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4730000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1719000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1458000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,16314000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2565000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,145000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,13168000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,19709000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1149000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,34171000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,,totalassets,Total Assets,=,debit,usd,53050000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2431000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8463000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10894000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,32935000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,5276000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,38211000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,49105000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,13097000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,2248000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-8839000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2561000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,3945000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,3945000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3945000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,,2015-12-31,2017-02-17 12:19:05+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,53050000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,9223000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,26000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4574000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1841000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1148000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1100000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,17912000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2546000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,74000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,13243000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,19822000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1235000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,34374000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,,totalassets,Total Assets,=,debit,usd,54832000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,768000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8045000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8813000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,35160000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,5996000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,41156000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,49969000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,13022000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,1654000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-7314000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2499000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,4863000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,4863000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,4863000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,,2015-09-30,2015-11-06 13:40:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,54832000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,7400000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,879000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4367000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1623000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1381000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1227000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,16877000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2517000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,134000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,13209000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,19937000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1181000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,34461000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,,totalassets,Total Assets,=,debit,usd,53855000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,4007000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7251000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11258000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,31034000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,6059000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,37093000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,48351000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,12438000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,1256000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-5816000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2374000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,5504000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,5504000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,5504000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,,2015-06-30,2015-08-07 13:58:41+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,53855000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,7906000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,18000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4214000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1022000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1050000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1198000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,15408000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2431000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,93000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,5534000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1478000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1755000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,8860000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,,totalassets,Total Assets,=,debit,usd,26699000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,4590000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6460000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11050000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,14272000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,14272000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,25322000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4419000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,739000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-1314000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2467000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1377000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1377000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1377000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,,2015-03-31,2015-05-08 16:15:17+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,26699000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,5100000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1323000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4758000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1444000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3562000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,16187000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2604000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1783000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,15416000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,28897000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1212000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,47308000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,,totalassets,Total Assets,=,debit,usd,66099000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,402000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9379000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9781000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,44792000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,6890000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,51682000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,61463000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,13696000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,4378000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-10852000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2586000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,4636000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,4636000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,4636000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,,2016-12-31,2018-02-16 12:40:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,66099000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,6218000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1732000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4999000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1630000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1711000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,16290000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2638000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1378000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,15657000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,29113000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1550000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,47698000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,,totalassets,Total Assets,=,debit,usd,66626000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,26000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9077000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9103000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,44930000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,6124000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,51054000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,60157000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,13558000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,4011000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-8760000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2340000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,6469000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,6469000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,6469000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,,2016-09-30,2016-11-07 12:52:37+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,66626000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,6327000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1675000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5048000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1756000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1985000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,16791000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2618000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1400000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,15507000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,29450000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1445000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,47802000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,,totalassets,Total Assets,=,debit,usd,67211000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,517000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8755000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9272000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,45119000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,7180000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,52299000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,61571000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,13064000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,3349000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-8383000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2390000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,5640000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,5640000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,5640000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,,2016-06-30,2016-08-05 12:24:41+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,67211000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,7556000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1044000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4753000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1789000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1480000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,16622000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2597000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,387000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,13274000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,19512000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1328000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,34501000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,,totalassets,Total Assets,=,debit,usd,53720000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2423000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8239000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10662000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,33003000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,5412000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,38415000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,49077000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,13311000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,2673000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-8918000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2423000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,4643000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,4643000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,4643000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,,2016-03-31,2016-05-06 12:22:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,53720000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,9303000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,486000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5088000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1605000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4741000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,21223000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2803000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2090000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,15785000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,27559000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1326000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,46760000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,,totalassets,Total Assets,=,debit,usd,70786000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,6415000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10226000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16641000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,46558000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,2490000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,49048000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,65689000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,14288000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,5459000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-11923000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2727000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,5097000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,5097000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,5097000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,,2017-12-31,2019-02-27 16:45:37+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,70786000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,8446000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1108000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4891000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1785000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2700000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,18930000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2697000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1971000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,15748000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,28167000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1327000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,47213000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,,totalassets,Total Assets,=,debit,usd,68840000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3821000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9212000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13033000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,42973000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,6147000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,49120000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,62153000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,14172000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,6547000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-11419000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2613000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,6687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,6687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,6687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,,2017-09-30,2017-11-07 11:27:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,68840000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,6088000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1117000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4859000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1582000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3316000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,16962000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2657000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2052000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,15652000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,28366000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1305000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,47375000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,,totalassets,Total Assets,=,debit,usd,66994000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3420000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8839000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,12259000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,42335000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,6391000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,48726000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,60985000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,14033000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,5951000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-11427000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2548000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,6009000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,6009000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,6009000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,,2017-06-30,2017-08-07 12:15:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,66994000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,4740000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1508000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4677000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1427000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3195000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,15547000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2612000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2123000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,15490000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,28629000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1263000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,47505000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,,totalassets,Total Assets,=,debit,usd,65664000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,425000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8419000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8844000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,45025000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,6797000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,51822000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,60666000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,13907000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,5063000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-11430000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2542000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,4998000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,4998000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,4998000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,,2017-03-31,2017-05-05 10:09:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,65664000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,7289000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,772000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5384000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1605000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1895000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,16945000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2883000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1420000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,15663000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,21233000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1208000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,39524000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,,totalassets,Total Assets,=,debit,usd,59352000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5308000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11931000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17239000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,49492000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1067000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,50559000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,67798000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,14774000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,3368000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-24108000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2480000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-8446000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-8446000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-8446000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,,2018-12-31,2020-02-21 10:51:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,59352000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,8015000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,770000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5780000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1786000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2114000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,18465000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2950000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1463000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,15718000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,26625000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,943000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,44749000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,,totalassets,Total Assets,=,debit,usd,66164000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,4021000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11366000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,15387000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,52208000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1490000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,53698000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,69085000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,14698000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,6789000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-21849000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2559000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-2921000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-2921000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-2921000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,,2018-09-30,2018-11-07 12:45:42+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,66164000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,3547000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,196000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5793000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1580000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2729000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,13845000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2787000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1505000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,15692000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,26903000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,909000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,45009000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,,totalassets,Total Assets,=,debit,usd,61641000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,6530000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10694000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17224000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,46122000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1670000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,47792000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,65016000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,14614000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,5495000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-20845000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2639000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-3375000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-3375000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-3375000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,,2018-06-30,2018-08-07 13:14:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,61641000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,9007000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,467000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5841000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1738000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3391000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,20444000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2828000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2057000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,15880000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,27230000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,903000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,46070000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,,totalassets,Total Assets,=,debit,usd,69342000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,6381000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10677000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17058000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,46427000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,2304000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,48731000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,65789000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,14537000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,4977000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-13331000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2630000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,3553000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,3553000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3553000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,,2018-03-31,2018-05-04 10:56:33+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,69342000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,39924000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5428000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1813000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2354000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,49519000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2962000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,93000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,15604000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,18649000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2288000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,36634000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,,totalassets,Total Assets,=,debit,usd,89115000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3753000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11832000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,15585000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,62975000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1130000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,17597000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,81702000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,97287000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,15211000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,4717000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-24504000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-3596000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-8172000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-8172000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-8172000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,,2019-12-31,2020-05-07 19:19:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,89115000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,10648000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5529000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1929000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2060000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,20166000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2894000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,131000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,15537000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,19036000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1677000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,36381000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,,totalassets,Total Assets,=,debit,usd,59441000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5276000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,12217000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17493000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,49116000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1058000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,50174000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,67667000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,15130000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,3673000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-24501000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2528000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-8226000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-8226000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-8226000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,,2019-09-30,2019-11-06 10:16:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,59441000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,5172000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,244000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5482000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1895000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2307000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,15100000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2879000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1473000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,15642000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,20459000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1589000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,39163000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,,totalassets,Total Assets,=,debit,usd,57142000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5641000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11300000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16941000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,47619000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1148000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,48767000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,65708000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,15046000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,3384000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-24505000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2491000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-8566000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-8566000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-8566000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,,2019-06-30,2019-08-05 12:33:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,57142000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,4897000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,331000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5680000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1702000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1803000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,14413000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2860000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1477000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,15606000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,20846000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1567000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,39496000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,,totalassets,Total Assets,=,debit,usd,56769000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2078000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11826000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13904000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,49575000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1116000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,50691000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,64595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,14958000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,4234000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-24502000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2516000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-7826000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-7826000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-7826000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,,2019-03-31,2019-05-03 10:28:05+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,56769000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,41142000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6362000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1844000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2410000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,51758000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2961000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,78000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,15561000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,18203000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2638000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,36480000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,,totalassets,Total Assets,=,debit,usd,91199000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3762000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,12709000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16471000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,63284000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,959000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,17900000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,82143000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,98614000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,15419000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,5973000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-25110000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-3697000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-7415000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-7415000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-7415000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,,2020-03-31,2020-05-07 19:19:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,91199000000.0
